VIRVir Biotechnology, Inc.

NAS · US · Healthcare · Biotechnology · vir.bio
9.780USD+0.10%Mkt Cap: 1.65B $P/E:

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical dev…

Key Statistics

Company
Market Cap1.65B $
Enterprise Value1.12B $
Revenue (TTM)303.23M $
Gross Profit66.49M $
Net Income (TTM)-437.99M $
Revenue/Share2.044 USD
Last Price9.780 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees367
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-3.70
PEG
EV/EBITDA-4.18
EV/Revenue3.69
P/S5.14
P/B1.83
EPS (TTM)-1.67
EPS (Forward)-2.49
52W Range
4.25075% of range11.66
52W High11.66 USD
52W Low4.250 USD
Profitability
Gross Margin99.96%
Oper. Margin30.75%
EBITDA Margin-88.37%
Profit Margin-658.43%
ROE-57.23%
ROA-43.68%
Growth
Revenue Growth19582.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-391.78M $
CapEx (TTM)4.83M $
FCF Margin-12.82%
FCF Yield-2.35%
Net Debt-439.45M $
Net Debt/EBITDA1.64
Balance Sheet
Debt/Equity0.13
Current Ratio6.04
Quick Ratio5.67
Book Value/Sh5.041 USD
Cash/Share3.148 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.00 USD
Upside (mean)+114.7%
Target Range15.00 USD30.00 USD
$15.00+114.7% to mean$30.00
# Analysts9
Ownership
Shares Out.169.22M
Float129.79M
Insiders6.57%
Institutions84.26%
Short Interest
Short Ratio12.1d
Short % Float11.39%
Short % Out.11.25%
Shares Short19.04M
Short (prev mo.)19.19M
Technical
SMA 509.340 (+4.7%)
SMA 2008.282 (+18.1%)
Beta1.59
S&P 52W Chg18.16%
Avg Vol (30d)1.52M
Avg Vol (10d)1.37M
Technical Indicators
RSI (14)62.4
MACD0.0459
MACD Signal-0.0719
MACD Hist.+0.1178
BB Upper9.692 USD
BB Middle9.030 USD
BB Lower8.369 USD
BB Width14.65%
ATR (14)0.4379 USD
Vol Ratio (20d)1.18x